You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復銳醫療(01696.HK)研發VorFat系統獲FDA批判在美上市
阿思達克 06-16 16:38
復銳醫療(01696.HK)公布,採用公司獨立研發的脂肪組織微粒化新技術的VorFat系統已於6月12日獲美國食品及藥物管理局(FDA)的許可,可以在美國上市。該設備於2022年11月29日在美國獲授專利。 該設備旨在將來自於吸脂設備所採集、濃縮和轉移的自體脂肪組織進行微粒化閉環處理並且用於醫學治療中再注射。該設備擬應用於自體脂肪移植以實現美體塑形,與此同時,還可以用於外科領域。目前公司已獲得該設備的廣泛適應症。 公司相信,FDA批准該設備將進一步加強公司的產品組合及產品競爭力,亦將鞏固公司作為全球美容市場的技術及市場領導者之一的地位。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account